SCHEMBL9797652

SCHEMBL9797652

C=CCc1ccc(OCc2ccc(OC)cc2)cc1

nearest known ligand 0.79

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.79
ALDH1A1 P00352 2/20 0.79
TP53 P04637 1/20 0.79
CYP3A4 P08684 1/20 0.79
ALOX15 P16050 1/20 0.79
TSHR P16473 1/20 0.79
ALOX12 P18054 1/20 0.79
APP P05067 7/20 0.61
MAOB P27338 1/20 0.59
NPC1 O15118 2/20 0.54
RAB9A P51151 2/20 0.54
POLB P06746 1/20 0.54
FFAR1 O14842 2/20 0.52
MAPT P10636 1/20 0.50
HTT P42858 1/20 0.50
TDP1 Q9NUW8 1/20 0.49
IDO1 P14902 1/20 0.48
AGXT P21549 1/20 0.48
PLA2G4B P0C869 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Estragole SCHEMBL57204 0.89 ALDH1A1 (1.00) SMN1; SMN2ALDH1A1TP53CYP3A4ALOX15
Estragole SCHEMBL900647 0.89 ALDH1A1 (1.00) SMN1; SMN2ALDH1A1TP53CYP3A4ALOX15
SCHEMBL8964647 0.88 ALDH1A1 (0.66) SMN1; SMN2ALDH1A1TP53CYP3A4ALOX15
Estragole SCHEMBL29777399 0.87 ALDH1A1 (0.96) SMN1; SMN2ALDH1A1TP53CYP3A4ALOX15
SCHEMBL20000873 0.84 APP (0.80) SMN1; SMN2ALDH1A1APPMAOBNPC1
SCHEMBL28567450 0.84 ALDH1A1 (0.60) SMN1; SMN2ALDH1A1TP53CYP3A4ALOX15
SCHEMBL8943028 0.84 APP (0.59) SMN1; SMN2ALDH1A1TP53CYP3A4ALOX15
SCHEMBL30083980 0.84 LMNA (0.58) SMN1; SMN2ALDH1A1TP53CYP3A4ALOX15
SCHEMBL933579 0.84 APP (0.62) SMN1; SMN2ALDH1A1TP53CYP3A4ALOX15
SCHEMBL9737615 0.84 APP (0.59) SMN1; SMN2ALDH1A1TP53CYP3A4ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0410380-A2 Novel process for the synthesis of 2-fluoro-1-olefins MERRELL DOW PHARMACEUTICALS INC. (US) 1991-01-30 EP disclosed